Login
$BIOF
$0.11 +$0.01 (11.04%) Close

Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Current Assets
Cash and Cash Equivalents
Grants receivable
Prepaid Expenses
TOTAL CURRENT ASSETS
Other Assets
Property and Equipment, net of accumulated depreciation and amortization of $541,850 and $482,578 at June 30, 2026 and December 31, 2025, respectively
Security Deposits
Right of Use Assets, net of accumulated amortization
Patents and Trademarks
Patents and Trademarks, net of accumulated amortization
TOTAL OTHER ASSETS
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Accounts Payable
Nonrelated Party
Related Party
Deferred wages and director’s fees - Related party
Related Party
Total deferred wages and director’s fees - Related party
Deferred Wages and Directors Fees - Related Parties
Right of Use Lease Liability - Current
Convertible Notes Payable
Nonrelated Party
Related Party
Convertible Notes Payable
Nonrelated Party
Related Party
Total convertible Notes Payable
Interest Payable - Related Parties
Related Party
Total interest Payable - Related Parties
TOTAL CURRENT LIABILITIES
Long Term Liabilities
Right of Use Lease Liability
Chapter 11 Settlement
Notes Payable — Related Party
Notes Payable — Related Parties
Convertible Notes Payable — Related Parties
Nonrelated Party
Related Party
Total convertible Notes Payable — Related Parties
Legacy Notes Payable — Other
Related Party
Total legacy Notes Payable — Other
TOTAL LONG TERM LIABILITIES
TOTAL LIABILITIES
STOCKHOLDERS’ DEFICIT
Common stock; $0.001 par value; 1,000,000,000 shares authorized; 323,518,980 and 317,872,112 issued and outstanding at June 30, 2026 and December 31, 2025, respectively.
Additional paid-in capital
Obligation to issue shares
Accumulated deficit
TOTAL STOCKHOLDERS’ DEFICIT
TOTAL EQUITY (DEFICIT)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support